0
Editor's Correspondence |

Possible Involvements of Vitamin K in Bone Quality

Toshihiro Sugiyama, MD, PhD
Arch Intern Med. 2007;167(1):93-94. doi:10.1001/archinte.167.1.93.
Text Size: A A A
Published online

Extract

Oral high-dose vitamin K2 (menaquinone-4, 45 mg/d) has been approved for the treatment of osteoporosis in Japan since 1995, and Cockayne and colleagues1 recently provided a meta-analysis of randomized controlled trials investigating the effects of vitamin K therapy on fracture risk. This analysis showed the strong effect of high-dose vitamin K2 on fracture prevention among Japanese patients. There is no evidence that vitamin K has extraskeletal effects on fracture risk, indicating that this vitamin would restrict bone fragility, which depends on its quantity and quality.2 However, the mechanisms by which vitamin K reduces fracture incidence have been poorly understood.

Topics

vitamin k

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
/>
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 2

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles
The Role of Rivaroxaban in Atrial Fibrillation and Acute Coronary Syndromes. J Cardiovasc Pharmacol Ther Published online Mar 21, 2014.;
Inflammatory, metabolic, and genetic mechanisms of vascular calcification. Arterioscler Thromb Vasc Biol 2014;34(4):715-23.
Jobs
brightcove.createExperiences();